Akero Therapeutics Ownership | Who Owns Akero Therapeutics?

Akero Therapeutics Ownership Summary

Akero Therapeutics is owned by 11.28% institutional investors, 1.41% insiders, and 87.31% retail investors. Blackrock is the largest institutional shareholder, holding 9.42% of AKRO shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.01% of its assets in Akero Therapeutics shares.

AKRO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Akero Therapeutics	11.28%	1.41%	87.31%
Sector	Healthcare Stocks	232.51%	10.72%	-143.22%
Industry	Biotech Stocks	384.55%	10.58%	-295.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	5.59M	9.42%	$131.06M
Janus henderson group	6.03M	8.69%	$167.77M
General atlantic	5.73M	7.02%	$272.25M
Rtw investments, lp	5.48M	6.70%	$260.07M
Wellington management group llp	4.25M	5.20%	$201.88M
Avoro capital advisors	3.96M	4.84%	$187.81M
Price t rowe associates inc /md/	3.81M	4.66%	$180.89M
Bellevue group	2.39M	2.92%	$113.44M
Boxer capital	1.68M	2.83%	$39.34M
Alkeon capital management	1.85M	2.26%	$87.88M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Allostery investments lp	22.50K	15.29%	$1.20M
General atlantic	5.73M	8.17%	$272.25M
B group	232.45K	8.12%	$11.04M
Logos global management lp	1.20M	5.11%	$56.98M
Foresite capital management vi	244.90K	4.49%	$11.63M
Redmile group	747.82K	3.45%	$35.51M
Rtw investments, lp	5.48M	3.20%	$260.07M
Avoro capital advisors	3.96M	2.43%	$187.81M
Bellevue group	2.39M	2.36%	$113.44M
Boxer capital	1.68M	2.07%	$39.34M

Top Buyers

Holder	Shares	% Assets	Change
Polar capital	1.06M	0.24%	1.06M
Wellington management group llp	4.25M	0.04%	841.91K
Blackrock	5.59M	0.00%	694.02K
Braidwell lp	475.40K	0.67%	475.40K
Weiss asset management lp	486.00K	0.28%	457.47K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-5.70M
Vanguard group	-	-	-4.53M
Deep track capital, lp	-	-	-4.00M
State street	-	-	-3.41M
Woodline partners lp	639.60K	0.14%	-1.83M

New Positions

Holder	Shares	% Assets	Change	Value
Polar capital	1.06M	0.24%	1.06M	$50.27M
Braidwell lp	475.40K	0.67%	475.40K	$22.57M
Hood river capital management	178.55K	0.10%	178.55K	$8.48M
Axa investment managers	71.20K	0.01%	71.20K	$3.38M
Cinctive capital management lp	31.90K	0.07%	31.90K	$1.51M

Sold Out

Holder	Change
Jfs wealth advisors	-1.00
Dinuzzo private wealth	-2.00
Tfc financial management	-2.00
Wealthspire advisors	-4.00
Twin peaks wealth advisors	-4.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2025	86	-68.27%	9,219,263	-89.50%	11	0.10%	30	-78.72%	35	-59.30%
Jun 30, 2025	279	8.98%	92,103,238	6.56%	112	0.93%	144	-14.29%	89	78.00%
Mar 31, 2025	28	-86.07%	15,857,543	-78.62%	20	0.18%	14	-87.16%	7	-86.00%
Dec 31, 2024	198	10.00%	74,179,472	1.61%	106	0.97%	107	27.38%	50	-12.28%
Sep 30, 2024	180	14.65%	72,997,386	1.71%	105	0.72%	85	8.97%	57	7.55%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	2.41M	3.01%	-50.45K
Vanguard US Total Market Shares ETF	1.94M	2.55%	2.50K
iShares Russell 2000 ETF	1.68M	2.11%	-
US Small-Cap Growth II Equity Comp	1.63M	2.04%	-184.44K
Janus Henderson Global Life Sciences	1.44M	1.80%	-117.23K
Janus Henderson Global Life Sciences D	1.44M	1.80%	-59.07K
T. Rowe Price New Horizons	1.34M	1.68%	-285.20K
Vanguard Health Care Inv	1.26M	1.58%	-2.40M
Janus Global Life Science AUSD	1.18M	1.48%	-75.10K
SPDR® S&P Biotech ETF	1.14M	1.42%	2.54K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 10, 2025	Cheng Andrew	President and CEO	Sell	$1.62M
Oct 07, 2025	Rolph Timothy	Chief Scientific Officer	Sell	$48.55K
Oct 07, 2025	Rolph Timothy	Chief Scientific Officer	Sell	$527.45K
Oct 01, 2025	Young Jonathan	Chief Operating Officer	Sell	$395.40K
Oct 01, 2025	Young Jonathan	Chief Operating Officer	Sell	$201.58K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	5
2025 Q3	-	29
2025 Q2	-	45
2025 Q1	4	39
2024 Q4	-	31

AKRO Ownership FAQ

Who Owns Akero Therapeutics?

Akero Therapeutics shareholders are primarily institutional investors at 11.28%, followed by 1.41% insiders and 87.31% retail investors. The average institutional ownership in Akero Therapeutics's industry, Biotech Stocks , is 384.55%, which Akero Therapeutics falls below.

Who owns the most shares of Akero Therapeutics?

Akero Therapeutics’s largest shareholders are Blackrock (5.59M shares, 9.42%), Janus henderson group (6.03M shares, 8.69%), and General atlantic (5.73M shares, 7.02%). Together, they hold 25.13% of Akero Therapeutics’s total shares outstanding.

Does Blackrock own Akero Therapeutics?

Yes, BlackRock owns 9.42% of Akero Therapeutics, totaling 5.59M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 131.06M$. In the last quarter, BlackRock increased its holdings by 694.02K shares, a 14.19% change.

Who is Akero Therapeutics’s biggest shareholder by percentage of total assets invested?

Allostery investments lp is Akero Therapeutics’s biggest shareholder by percentage of total assets invested, with 15.29% of its assets in 22.5K Akero Therapeutics shares, valued at 1.2M$.

Who is the top mutual fund holder of Akero Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Akero Therapeutics shares, with 3.01% of its total shares outstanding invested in 2.41M Akero Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools